Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.051 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.7 |